Get the Stockscreener App
0.65
2.15%
-0.0143
Pre-market:
.65
Enzo Biochem Inc stock is traded at $0.65, with a volume of 107.28K.
It is down -2.15% in the last 24 hours and down -36.27% over the past month.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
See More
Previous Close:
$0.6643
Open:
$0.66
24h Volume:
107.28K
Relative Volume:
0.74
Market Cap:
$33.96M
Revenue:
$20.59M
Net Income/Loss:
$24.31M
P/E Ratio:
1.30
EPS:
0.5
Net Cash Flow:
$-44.02M
1W Performance:
-7.84%
1M Performance:
-36.27%
6M Performance:
-43.97%
1Y Performance:
-53.24%
1-Day Range:
$0.65
$0.68
1-Week Range:
$0.6477
$0.7201
52-Week Range:
$0.6477
$1.436
Enzo Biochem Inc Stock (ENZ) Company Profile
Name
Enzo Biochem Inc
Sector
Industry
Phone
(516) 755-5500
Address
60 EXECUTIVE BLVD, FARMINGDALE, NY
Compare ENZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
0.65 | 33.96M | 20.59M | 24.31M | -44.02M | 0.50 |
|
TMO
Thermo Fisher Scientific Inc
|
556.99 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
237.62 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
143.43 | 40.54B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.96 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
418.63 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-18-11 | Reiterated | Rodman & Renshaw | Mkt Outperform |
| Sep-23-09 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Sep-13-07 | Initiated | Lazard Capital | Buy |
Enzo Biochem Inc Stock (ENZ) Latest News
Enzo Biochem Receives Notice from NYSE Regarding Listing ComplianceFarmingdale, NY – Enzo Biochem, Inc. (NYSE: ENZ) recently disclosed that it received a notice from the New York Stock Exchange (NYSE) indicating non-compliance with certain listing - Defense World
Enzo Biochem Faces NYSE Compliance Challenges - TipRanks
Enzo Biochem faces NYSE compliance challenges - Investing.com India
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules - The Manila Times
Enzo Biochem Receives NYSE Non-Compliance Notice Over Market Cap and Share Price Issues - StockTitan
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges - MSN
Enzo Biochem (NYSE:ENZ) versus Grail (NASDAQ:GRAL) Financial Review - Defense World
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.68 amid challenges - Investing.com Nigeria
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com - Defense World
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World
Enzo Biochem (ENZ) Stock Surges 5.19% Amid Market Activity - GuruFocus.com
Enzo Biochem, Inc.'s (NYSE:ENZ) 33% Share Price Plunge Could Signal Some Risk - Simply Wall St
Enzo Biochem First Quarter 2025 Earnings: US$0.059 loss per share (vs US$0.11 loss in 1Q 2024) - Yahoo Finance
Enzo Biochem stock hits 52-week low at $0.92 amid challenges - Investing.com
Enzo Biochem: Fiscal Q1 Earnings Snapshot - Midland Daily News
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - MarketBeat
Enzo Biochem, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2024 - Marketscreener.com
Enzo Biochem Reports Narrowed Loss Amid Revenue Decline - TipRanks
ENZEnzo Biochem, Inc. Latest Stock News & Market Updates - StockTitan
Enzo Biochem (NYSE:ENZ) Announces Quarterly Earnings Results - MarketBeat
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) reports earnings - Quartz
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update - GlobeNewswire
Enzo Biochem Reports 20% Revenue Drop Amid Life Sciences Slowdown; Maintains $47.7M Cash Position - StockTitan
The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem - Yahoo Finance
Top Stock Reports for Amgen, Eaton & Enzo Biochem - Yahoo Finance
US Penny Stocks To Watch In December 2024 - Simply Wall St
Enzo Biochem, Inc. (NYSE:ENZ) Sees Large Drop in Short Interest - MarketBeat
Flow Cytometer Market to Expand by USD 8.17 Billion (2024-2028), Rising R&D Investments Drive Growth, Report on AI's Impact on Market TrendsTechnavio - The Malaysian Reserve
Enzo Biochem Appoints Jon Couchman to Board - TipRanks
Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com - MarketBeat
Enzo Biochem stock hits 52-week low at $0.99 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem stock hits 52-week low at $0.99 amid market challenges - Investing.com Canada
Oxidative Stress Assay Market Geographical Segmentation, - openPR
Will Enzo Biochem (NYSE:ENZ) Spend Its Cash Wisely? - Simply Wall St
We're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn Rate - Yahoo Finance
Enzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023) - Yahoo Finance UK
ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands - MSN
Enzo Biochem Reports Revenue Growth Despite Losses - TipRanks
Enzo Biochem Inc Stock (ENZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):